Couple sues fertility clinic after discovering daughter conceived with unidentified man's sperm
A Florida couple has filed a lawsuit against Brown Fertility clinic alleging that the facility used sperm from an unidentified man instead of the husband's during their IVF treatment. The error was discovered when newborn screening revealed the infant's blood type was incompatible with both parents, with subsequent DNA testing confirming the child was not biologically related to the father. The couple is seeking damages exceeding $50,000 and is concerned about the whereabouts of the husband's cryopreserved sperm and whether it may have been used in other patients' treatments.
The error came to light through routine newborn screening, which identified a blood type incompatibility that prompted further investigation. The child's B-positive blood type could not have come from either parent, leading the couple to pursue DNA testing that definitively established the husband was not the biological father. This discovery was particularly significant given that the husband had undergone a surgical sperm retrieval procedure specifically for the IVF treatment, making the substitution a serious breach of medical protocol.
The couple's concerns extend beyond their immediate situation. They are uncertain about the fate of the husband's cryopreserved sperm samples, raising questions about whether proper storage protocols were followed and whether genetic material from other patients may have been similarly mishandled. These concerns reflect broader accountability issues within assisted reproductive medicine regarding sample tracking and chain-of-custody procedures.
This case highlights potential vulnerabilities in fertility clinic operations, particularly around specimen identification and storage protocols. If widespread, such errors could undermine patient trust in assisted reproductive technology and raise questions about regulatory oversight of fertility facilities. The incident may prompt increased scrutiny of laboratory practices, chain-of-custody procedures, and incident reporting requirements across the fertility industry. Additionally, the case could influence how courts assess damages in medical negligence cases involving reproductive services and genetic identity.